Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

DIAsource

DIAsource
1996 FOUNDED
M&A STATUS
71-80 EMPLOYEES
Buyout/LBO LATEST DEAL TYPE
3 FINANCING ROUNDS
2 INVESTMENTS
Description

Manufacturer, developer and marketer of clinical diagnostics products designed to treat endocrinology and infectious diseases. The company's focus lies in offering a panel of accurate, reliable assays that allow the performant detection and measurement of various forms of Vitamin D metabolites, as well as developing new antibodies and assays to measure relevant biomarkers, enabling clients to detect and monitor endocrine disorders and infectious and auto-immune diseases.

Formerly Known As
Biosource Europe, Medgenics
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Other Pharmaceuticals and Biotechnology
Primary Office
  • Rue du Bosquet, 2
  • 1348 Louvain-la-Neuve
  • Belgium

+32 010 00 00 00

DIAsource Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore DIAsource‘s full profile, request access.

Request full access to PitchBook

DIAsource Competitors (26)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Akonni Biosystems Venture Capital-Backed Frederick, MD 00 000.00 0000000000 0 000.00
00000000 000000000 Formerly PE-Backed Fremont, CA 000 000 000000000000 000
000000000 Formerly VC-backed Mechelen, Belgium 000 00000 000000000 00000
0000000 00000 Private Equity-Backed Puteaux, France 000 000.00 000000000000
000000 000000000 Formerly PE-Backed Codolet, France 000 000000&0
To view this company’s complete list of competitors, request access »

DIAsource Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 0000 0000000 30-Jul-2018 000000000 00000 00 Drug Discovery
Viro-Immun Diagnostics 01-Sep-2017 Merger/Acquisition Diagnostic Equipment
To view this company’s complete investment and acquisition history, request access »

DIAsource Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore DIAsource‘s full profile, request access.

Request full access to PitchBook

DIAsource Executive Team (4)

Name Title Board
Seat
Contact
Info
BĂ©atrice de Borman Chief Executive Officer
Corentin Frippiat Financial Controller
Peter Kerckx International Sales Director & Business Segment Manager RIA

1 Former Executive

You’re viewing 3 of 4 executives. Get the full list »

DIAsource Board Members (1)

Name Representing Role Since Contact
Info
0000 0000000 00.0 Self Interim Executive Chairman 000 0000